Optimizing classification of acute myocardial infarction: from diagnosis to prognosis.

Physiol Rev 1990; 70: 427–51. [7] Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 257: 387–9. [8] Wang P, Zweier JL. Measurement of nitric oxide and peroxynitrite generation in the postischaemic heart: evidence for peroxynitrite-mediated reperfusion injury. J Biol Chem 1996; 271: 29223–30. [9] Comini L, Bachetti T, Agnoletti L et al. Induction of functional inducible nitric oxide synthase in monocytes of patients with congestive heart failure: link with tumour necrosis factor á. Eur Heart J 1999; 20: 1503–13. [10] Wiedermann CJ, Beimpold H, Herold M, Knapp E, Braunsteiner H. Increased levels of serum neopterin and decreased production of neutrophil superoxide anions in chronic heart failure with elevated levels of tumor necrosis factor-á. J Am Coll Cardiol 1993; 22: 1897–901. [11] Hegewisch S, Weh HJ, Hossfeld DK. TNF-induced cardiomyopathy. Lancet 1990; 21: 171–2. [12] Matsumori A, Ono K, Nishio R, Nose Y Sasayama S. Amiodarone inhibits production of tumor necrosis factor-á by human mononuclear cells. A possible mechanism for its effect in heart failure. Circulation 1997; 96: 1386–9. [13] Wagner DR, Combes A, McTiernan C, Sanders VJ, Lemster B, Feldman AM. Adenosine inhibits lipopolysaccharideinduced cardiac expression of tumor necrosis factor-á. Circ Res 1998; 82: 47–56. [14] Sliwa K, Skudicky D, Candy G, Wisenbaugh T, Sareli P. Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy. Lancet 1998; 351: 1091–3.